Dunne Michael W.
Related Filers (3)
- Iterum Therapeutics plc (28)
- Durata Therapeutics, Inc. (6)
- Aviragen Therapeutics, Inc. (4)
- Show More ...
Ownership (38)
4
Wednesday, 12/27/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/19/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Monday, 11/27/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Monday, 10/2/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4/A
Monday, 6/5/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4/A
Monday, 2/27/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/28/2022
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/27/2022
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Friday, 9/9/2022
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/28/2022
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/29/2022
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/27/2021
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Friday, 6/25/2021
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Monday, 3/29/2021
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/27/2021
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/28/2020
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/19/2019
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Thursday, 9/6/2018
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/28/2018
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/30/2018
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/29/2018
Iterum Therapeutics plc: Statement of changes in beneficial ownership of securities
3
Thursday, 5/24/2018
Iterum Therapeutics plc: Initial statement of beneficial ownership of securities
4
Monday, 5/22/2017
Aviragen Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/13/2016
Aviragen Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/21/2015
Biota Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/21/2015
Biota Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/18/2014
Durata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/22/2014
Durata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
5
Thursday, 2/14/2013
Durata Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
4
Thursday, 2/14/2013
Durata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/26/2012
Durata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/18/2012
Durata Therapeutics, Inc.: Initial statement of beneficial ownership of securities